{"id":9443,"date":"2012-11-02T00:00:00","date_gmt":"2012-11-01T23:00:00","guid":{"rendered":"https:\/\/idibell.cat\/blog\/2012\/11\/02\/bonaventura-clotet-estem-treballant-en-una-vacuna-terapeutica-per-evitar-que-el-vih-es-propagui-duna-cel%c2%b7lula-a-una-altra\/"},"modified":"2022-03-07T17:20:09","modified_gmt":"2022-03-07T16:20:09","slug":"bonaventura-clotet-estem-treballant-en-una-vacuna-terapeutica-per-evitar-que-el-vih-es-propagui-duna-cellula-a-una-altra","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2012\/11\/bonaventura-clotet-estem-treballant-en-una-vacuna-terapeutica-per-evitar-que-el-vih-es-propagui-duna-cellula-a-una-altra\/","title":{"rendered":"Bonaventura Clotet: ”Estem treballant en una vacuna terap\u00e8utica per evitar que el VIH es propagui d’una c\u00e8l\u00b7lula a una altra”"},"content":{"rendered":"

El seminari IDIBELL del 28 d’octubre, amb el t\u00edtol “Update about HIV Eradication”, va ser impartit pel Dr Bonaventura Clotet, investigador i director de l’Institut de Recerca de la Sida (IrsiCaixa), i es va centrar en les diferents estrat\u00e8gies actuals per guarir el VIH. Invitat pel Dr. Manel Esteller.<\/p>\n

El problema de la difusi\u00f3 i tractament del VIH \u00e9s que cada vegada hi ha un major nombre de nous casos i el tractament \u00e9s de per vida, tenint un elevat cost, tant hum\u00e0 com econ\u00f2mic. Aquest \u00faltim est\u00e0 sobre els 4.000 euros\/persona i any. “Hem de reduir el cost del tractament”, va dir el doctor Clotet.<\/p>\n

“Hem vist que la ter\u00e0pia antiretroviral de gran activitat (TARGA) \u00e9s efica\u00e7”, va continuar el director d’IrsiCaixa. S’ha demostrat que la supressi\u00f3 a nivells per sota del que detectable del VIH-1 \u00e9s efica\u00e7. No obstant aix\u00f2, persisteix un baix nivell de virul\u00e8mia (c\u00e0rrega viral) en plasma. I l’activaci\u00f3 immune disminueix, per\u00f2 no es normalitza. Ja fa una d\u00e8cada es va indicar en un estudi que l’eradicaci\u00f3 del virus \u00e9s poc probable.<\/p>\n

“Com s’explica l’extremada persist\u00e8ncia del dip\u00f2sit virus?”, Va preguntar el Dr. Clotet. TARGA det\u00e9 tota la replicaci\u00f3 viral per\u00f2 la replicaci\u00f3 residual continua pel fet que HAART no completa la supressi\u00f3.<\/p>\n

La hip\u00f2tesis \u00e9s que el TARGA atura la replicaci\u00f3 activa i la lat\u00e8ncia permet la persist\u00e8ncia de tota la vida del virus.<\/p>\n

Estrat\u00e8gies per guarir el VIH<\/strong><\/p>\n

Els investigadors d\u2019IrsiCaixa havien iniciat un estudi uns anys abans, en qu\u00e8 volien saber si la intensificaci\u00f3 per Raltergravir del tractament HAART produ\u00efa una millora del mateix. Van veure una disminuci\u00f3 de l’activaci\u00f3 dels par\u00e0metres relacionats amb la difusi\u00f3 del VIH. “Vam arribar a la conclusi\u00f3 que la intensificaci\u00f3 de la ter\u00e0pia HAART amb Raltergravir tenia una disminuci\u00f3 dels reservoris”, digu\u00e9 el doctor Clotet.<\/p>\n

Despr\u00e9s de l’estudi, que va rebre moltes cr\u00edtiques, van decidir fer una altra recerca sobre la intensificaci\u00f3 d’aquest tractament. Es va focalitzar sobre els pacients recentment infectats, amb la finalitat d’investigar aquesta hip\u00f2tesi i es van aconseguir els mateixos resultats que en l’estudi previ. El tractament primerenc va ser un punt clau per disminuir els reservoris.<\/p>\n

Pot una vacuna terap\u00e8utica treballar juntament amb un agent anti-lat\u00e8ncia?<\/strong><\/p>\n

Hi ha alguns models possibles per a la curaci\u00f3 funcional. “Per\u00f2, hi ha un control immunol\u00f2gic dels reservoris del VIH? Pot la immunitat espec\u00edfica del VIH controlar els reservoris del VIH? Treballem en un assaig d’una vacuna contra el VIH des de 2008. Una vacuna terap\u00e8utica hauria d’induir c\u00e8l\u00b7lules anti-VIH, T CD8 o ABS, per eliminar les c\u00e8l\u00b7lules replicants residuals o bloquejar la propagaci\u00f3 del VIH c\u00e8l\u00b7lula a c\u00e8l\u00b7lula”, va dir l’investigador.<\/p>\n

Una altra estrat\u00e8gia prometedora<\/strong><\/p>\n

El Dr Clotet va concloure la seva confer\u00e8ncia parlant de Timothy Brown, la primera persona que s’ha curat de VIH. Brown tenia leuc\u00e8mia i va ser tractat mitjan\u00e7ant el trasplantament de c\u00e8l\u00b7lules mare. El donant tenia el gen CCR5 alterat. Despr\u00e9s, es va demostrar la curaci\u00f3. Aquest tipus de tractament \u00e9s ben tolerat. Aquest enfocament ha estat patentat, de manera que la resta d’investigadors no el poden fer servir.<\/p>\n","protected":false},"excerpt":{"rendered":"

El seminari IDIBELL del 28 d’octubre, amb el t\u00edtol “Update about HIV Eradication”, va ser impartit pel Dr Bonaventura Clotet, investigador i director de l’Institut de Recerca de la Sida (IrsiCaixa), i es va centrar en les diferents estrat\u00e8gies actuals per guarir el VIH. Invitat pel Dr. Manel Esteller. El problema de la difusi\u00f3 i […]<\/p>\n","protected":false},"author":6,"featured_media":20842,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[491,493],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-10 06:37:44","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/9443"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=9443"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/9443\/revisions"}],"predecessor-version":[{"id":20844,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/9443\/revisions\/20844"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/20842"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=9443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=9443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=9443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}